| __timestamp | Arrowhead Pharmaceuticals, Inc. | MorphoSys AG |
|---|---|---|
| Wednesday, January 1, 2014 | 23138050 | 55962693 |
| Thursday, January 1, 2015 | 57410147 | 78655788 |
| Friday, January 1, 2016 | 41454452 | 95723069 |
| Sunday, January 1, 2017 | 31690298 | 116808575 |
| Monday, January 1, 2018 | 52968505 | 106397017 |
| Tuesday, January 1, 2019 | 81048686 | 108431600 |
| Wednesday, January 1, 2020 | 128874979 | 141426832 |
| Friday, January 1, 2021 | 206342000 | 225200000 |
| Saturday, January 1, 2022 | 297307000 | 297812160 |
| Sunday, January 1, 2023 | 353188000 | 283614139 |
| Monday, January 1, 2024 | 505870000 |
Infusing magic into the data realm
In the competitive world of biotechnology, innovation is the key to success. Over the past decade, Arrowhead Pharmaceuticals, Inc. and MorphoSys AG have been at the forefront of this race, investing heavily in research and development (R&D). From 2014 to 2023, Arrowhead Pharmaceuticals has shown a remarkable growth trajectory, increasing its R&D expenses by over 1,400%, peaking in 2023. In contrast, MorphoSys AG, while also increasing its investment, saw a more modest growth of around 400% over the same period.
Arrowhead's aggressive investment strategy is evident, especially in the last few years, where it surpassed MorphoSys in R&D spending. This shift highlights Arrowhead's commitment to innovation, potentially positioning it as a leader in the biotech industry. However, the data for 2024 is incomplete for MorphoSys, leaving room for speculation on its future strategy.
Johnson & Johnson or Arrowhead Pharmaceuticals, Inc.: Who Invests More in Innovation?
R&D Insights: How Merck & Co., Inc. and Arrowhead Pharmaceuticals, Inc. Allocate Funds
Biogen Inc. or MorphoSys AG: Who Invests More in Innovation?
R&D Spending Showdown: BeiGene, Ltd. vs MorphoSys AG
Analyzing R&D Budgets: Jazz Pharmaceuticals plc vs Arrowhead Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Halozyme Therapeutics, Inc. and MorphoSys AG
R&D Spending Showdown: Ultragenyx Pharmaceutical Inc. vs MorphoSys AG
Who Prioritizes Innovation? R&D Spending Compared for Apellis Pharmaceuticals, Inc. and MorphoSys AG
Xenon Pharmaceuticals Inc. or Arrowhead Pharmaceuticals, Inc.: Who Invests More in Innovation?
MorphoSys AG or Arrowhead Pharmaceuticals, Inc.: Who Leads in Yearly Revenue?
R&D Insights: How Arrowhead Pharmaceuticals, Inc. and Agios Pharmaceuticals, Inc. Allocate Funds
Research and Development Expenses Breakdown: Arrowhead Pharmaceuticals, Inc. vs Viridian Therapeutics, Inc.